Concurrently, when we measured the arginine levels in plasma obtained from 41 CRPS patients and in 20 control samples that were used in the miRNA profiling study8, we found that patients with CRPS had significantly decreased arginine levels (Fig. 6A), possibly indicating increased levels or activity of NOS2. The gene discussed is NOS2; the disease is complex regional pain syndrome.